Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trans-6-(2-phenylyclopropyl)-naphthalene‑2‑carboxamidine is a synthetic small molecule with the molecular formula C20H18N2 and a molecular weight of approximately 286.4 g/mol[1][3][5]. It belongs to the chemical class of phenylpropanoids and polyketides, specifically stilbenes[5]. The compound is listed as experimental and does not have any approved medical indications or known clinical development activity beyond preclinical research[5]. Its mechanism of action and biological targets are not well characterized in public databases. There are no known brand names or marketed formulations for this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trans-6-(2-phenylcyclopropyl)-naphthalene-2-carboxamidine.